I50.9
Conditions
Interventions
Group 1: Patients who already have the CMIC system implanted
Sponsors
Berlin Heals GmbH
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients from the per protocol treatment group who have received a C-MIC System during the SPOT C-MIC Study. Informed consent in writing from the patient
Exclusion criteria
Exclusion criteria: Patients who are unwilling or unable to participate in the study visits.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective to assess the safety of the C-MIC System in case of: • C-MIC System extended use or • C-MIC System abandonment or • C-MIC System explantation in patients having received a C-MIC System in the context of a prior study. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary objective of this study is to assess the duration of improvement in cardiac performance reached through therapy with the C-MIC System regarding: • Performance outcomes • Clinician-reported outcome • Patient related outcome | — |
Countries
Serbia
Contacts
Public ContactMiodrag Peric
Institute of Cardiovascular Diseases Dedinje
Outcome results
None listed